Dxcover
2 known investors
Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage. The platform is aimed at triaging high-risk populations for high-mortality cancers.
Investors · 2
Competitors · 7
by search overlapEarlydx5 shared keywordsEarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine. The company positions its tests as accurate and affordable diagnostics.
Foresight Dx3 shared keywordsForesight Diagnostics develops ultra-sensitive molecular diagnostic tests that combine genomics and bioinformatics to detect minimal residual disease and circulating tumor DNA across multiple cancer types. Its offerings support oncology drug development, clinical trials, and patient care for academic and biopharma partners.
Digital Diagnostics3 shared keywordsHealthcare technology company whose FDA-cleared autonomous AI diagnoses diabetic retinopathy from retinal images at the point of care.
Labcorp3 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Smarter Dx3 shared keywordsSmarterDx provides a clinical AI platform that helps hospitals and health systems improve documentation, coding, and revenue cycle management by accurately capturing the complexity of patient care. The platform assists health systems in recovering revenue, improving quality scores, and streamlining workflows across the revenue cycle.
Pinkdx3 shared keywordsPinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
CareDx3 shared keywordsCareDx provides molecular diagnostic testing, workflow software, patient support, and pharmacy services for care teams working in transplant, cell therapy, and specialty oncology. Its products support rejection monitoring and complex care management in precision medicine.
Companies competing with Dxcover for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Dxcover do?
- Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage. The platform is aimed at triaging high-risk populations for high-mortality cancers.
- Who are Dxcover's investors?
- Dxcover's investors include Alba Equity, Eos Advisory.